Biogen (BIIB) Interest & Investment Income (2011 - 2012)
Biogen (BIIB) posted quarterly Interest & Investment Income of $1.9 million for Q1 2012, up 116.2% year-over-year from $883902.1 in Q2 2011, and up 116.2% quarter-over-quarter from -$11.8 million in Q1 2011.
Biogen (BIIB) Interest & Investment Income (2011 - 2012) Analysis & Trends
Biogen's Interest & Investment Income history runs 2 years deep, the most recent figure standing at $1.9 million for Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | - |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | - |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 77.82 Mn |
| 10 | Biogen | 32.04 Bn | 30.76 Bn | 1.96 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 1.91 Mn |
| Mar 31, 2011 | -11.80 Mn |